Phase II Trial of Tacrolimus and Rapamycin vs. Tacrolimus and Methotrexate as GVHD Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation.
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2015
At a glance
- Drugs Methotrexate (Primary) ; Sirolimus (Primary) ; Tacrolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 29 Jun 2012 Planned end date changed from 1 Sep 2011 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 12 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.